Table 3 Comparison of parameters of patients with low and high vFMR

Age at diagnosis, year

51.97 ± 13.40

60.79 ± 11.20

< 0.001^*

BMI, kg/m²

21.99 ± 2.81

25.62 ± 4.82

< 0.001^*

Visceral fat area, cm²

42.81 ± 21.38

140.33 ± 66.99

< 0.001^*

Subcutaneous fat area, cm²

114.08 ± 49.84

177.50 ± 64.39

< 0.001^*

SMA, cm²

101.36 ± 15.85

102.81 ± 17.06

0.588^*

Skeletal muscle attenuation

45.33 ± 8.58

39.19 ± 8.99

< 0.001^*

Skeletal muscle index

40.78 ± 6.26

42.48 ± 6.03

0.092^*

WBC, /μL

6,616.40 ± 1,790.30

7,338.70 ± 2,596.49

0.055^*

Absolute neutrophil count, /μL

4,331.50 ± 1,641.54

5,016.50 ± 2,496.38

0.056^*

Lymphocyte, /μL

1,674.40 ± 661.43

1,686.50 ± 650.75

0.911^*

Neutrophil to lymphocyte ratio

3.15 ± 2.27

3.66 ± 3.31

0.265^*

Hemoglobin, g/dL

11.93 ± 1.62

12.14 ± 1.52

0.392^*

Platelet, 10³/μL

288.33 ± 96.23

334.39 ± 117.89

0.011^*

Albumin, g/dL

3.94 ± 0.53

3.94 ± 0.39

0.980^*

PNI

49.11 ± 6.07

47.70 ± 6.55

0.179^*

 < 60

63

29

< 0.001^†

 ≥ 60

23

38

 No

70

35

< 0.001^†

 DM or HTN

16

32

 No

40

15

0.002^†

 yes

46

52

 < 25

71

31

< 0.001^†

 ≥ 25

15

36

 serous

48

52

0.005^†

 non-serous

38

15

 PDS

80

55

0.037^†

 NAC

6

12

 Optimal

65

50

0.892^†

 suboptimal

22

16

 1

37

12

NS^††

 2

3

5

 3

32

39

 4

14

11

 sensitive

61

51

0.896^†

 resistant

12

8

 unknown

4

3

 No

48

27

0.15^†

 recur

31

34

 F/U loss

7

6

 < 38.7

34

17

0.065^†

 ≥ 38.7

52

50